news

Pathogen busting bacteriophage found in a pond

Posted: 26 May 2016 | Victoria White, Digital Content Producer | No comments yet

A bacteriophage, found in a pond in Connecticut, attacks a common multi-drug resistant bacterial pathogen called Pseudomonas aeruginosa…

A bacteriophage, discovered by Yale researchers in Dodge Pond in East Lyme, Connecticut, has been found to attack a common multi-drug resistant bacterial pathogen called Pseudomonas aeruginosa, which can lethally infect people with compromised immune systems.

The virus attaches to the cell membrane where bacteria pump out antibiotics, a system that had originally evolved to resist antibiotics. The presence of the virus in turn leads to evolutionary changes in the bacterial membrane that makes this pumping mechanism less efficient. This makes bacteria once more susceptible to existing antibiotics.

“We have been looking for natural products that are useful in combating important pathogens,” said Paul Turner, professor and chair of the Department of Ecology and Evolutionary Biology. “What’s neat about this virus is it binds to something the organism needs to become pathogenic, and backs it into an evolutionary corner such that it becomes more sensitive to currently failing antibiotics.”

 

Reserve your FREE place

 


Are low affinity or poor TCR yields slowing you down?

Explore how CHO expression of soluble TCRs and TCR affinity maturation workflows via phage, serving as essential building blocks for early-stage TCR-TCE candidate generation.

22 October 2025 | 16:00 PM BST | FREE Webinar

Join Jiansheng Wu, Ph.D. to explore two integrated strategies:

  • High-titer CHO-based expression of sTCRs (~100 mg/L), enabling scalable and high-throughput production
  • Optimized phage display affinity maturation, improving TCR binding by up to ~10,000-fold

Whether you’re starting a new TCR program or optimizing an existing platform, this session will offer actionable strategies to accelerate discovery and improve candidate quality.

Register Now – It’s Free!

 

The virus should help preserve our limited antibiotic arsenal in combating deadly bacteria, he said.

This “phage” therapy could be used in conjunction with antibiotics to treat dangerous P. aeruginosa infections that afflict patients with severe burns, surgical wounds, cystic fibrosis, and other conditions that compromise the immune system.

Turner also noted that other phages hold promise to combat bacterial pathogens that cause economic losses in plant and animal agriculture, and those that contaminate pipes and equipment such as bioreactors in food manufacturing.

Related topics

Related organisations

Related people

Leave a Reply

Your email address will not be published. Required fields are marked *